<?xml version="1.0" encoding="UTF-8"?>
<p id="par0290">
 <list list-type="simple" id="lis0020">
  <list-item id="lsti0045">
   <label>â€¢</label>
   <p id="par0295">The extensive requirement for protein cleavage during the coronavirus replication cycle has made the viral papain-like (Plpro) and chymotrypsin-like (3Clpro) proteases major targets for drug development. Highly specific small-molecule inhibitors of both enzymes have been identified that inhibit the SARS coronavirus, and might also be used to image infections (
    <xref rid="bib0255" ref-type="bibr">Ghosh et al., 2008</xref>, 
    <xref rid="bib0455" ref-type="bibr">Ratia et al., 2008</xref>).
   </p>
  </list-item>
 </list>
</p>
